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loss-of-function mutant flies, showing that JAK signaling may, under some conditions, contribute to TotA induc-
tion. However, the Tot genes are induced by a varietyis necessary and sufficient for TotA induction. Not only
TotA, but also TotM, TotC, and probably the other Turan- of different stress factors, most of which do not affect
the expression of antibacterial peptides. This arguesdot genes as well, are regulated in the same way
(Boutros et al., 2002; Agaisse et al., 2003). Although against a general requirement for Relish in Tot gene
induction. An interesting question is whether Upd3 anddirect evidence is lacking, it is likely that this signal is
the JAK/STAT pathway are involved in all cases. It ismediated by the Drosophila STAT gene. It was pre-
possible that other signaling pathways mediate the re-viously shown that STAT becomes translocated to the
sponse to some stimuli.nucleus in the fat body of mosquitoes after a bacterial
The upd3 gene forms a cluster together with the ho-challenge (Barillas-Mury et al., 1999), and now the same
mologous upd and upd2 genes (Castelli-Gair Hombrı´athing is demonstrated to happen in Drosophila (Agaisse
and Brown, 2002; Agaisse et al., 2003). None of themet al., 2003).
is obviously related to mammalian cytokines, but theMany mammalian cytokines act via a JAK/STAT sig-
results of Agaisse et al. demonstrate that at least Upd3naling pathway. The results of Agaisse et al. (2003) pro-
can act as a cytokine in the activation of Turandot pep-vide strong evidence that a cytokine also initiates the
tide secretion. It mediates a signal from the hemocytesJAK/STAT-mediated induction of TotA in the Drosophila
to a cytokine receptor homolog in the fat body, activat-fat body. So far, two cytokine receptor homologs have
ing the JAK/STAT pathway in a way that is highly remi-been identified in the Drosophila genome. At least one of
niscent of cytokine signaling in mammals. This makesthem, Dome, plays a role during development, activating
Drosophila an interesting model for the cytokine field.JAK/STAT signaling in response to a secreted ligand,
Unpaired (Upd; Castelli-Gair Hombrı´a and Brown, 2002).
Dan Hultmark1 and Sophia Ekengren2Agaisse et al. (2003) now overexpressed a dominant-
1Umea˚ Centre for Molecular Pathogenesisnegative version of Dome, and found that this blocks
Umea˚ UniversityTotA induction in the fat body. However, in this case,
S-901 87 Umea˚the relevant ligand does not appear to be Upd itself
Swedenbut a related protein, Upd3, which is expressed in the
2 Boyce Thompson Institute for Plant Researchhemocytes. Inactivation of the corresponding upd3
Cornell Universitygene by RNAi in the hemocytes, but not in the fat body,
Tower Roadblocks TotA induction. This provides a long-sought link
Ithaca, New York 14853between signaling in the hemocytes and the fat body.
The Turandot peptides are not the only peptides pro-
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Hippo restricts cell growth and cell proliferation, pro-Coupling Cell Growth,
motes cell death, and interacts with the tumor sup-Proliferation, and Death: pressors Salvador and Warts. This, together with the
ability of Mst2 to rescue hippo mutant phenotypes,Hippo Weighs In
argues that Mst/Hippo proteins are tumor sup-
pressors.
Tissue size is determined by the relationship betweenFour recent papers describe the characterization in
Drosophila of Hippo, a serine/threonine kinase of the cell size, cell proliferation, and cell death. Normally,
these processes are balanced so that tissue size in theSterile 20 (STE20) group, resembling Mst1 and Mst2.
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adult remains constant over time. Tumor suppressors et al., 2002; Wu et al., 2003; Udan et al., 2003), suggesting
that Hpo, Sav, and Wts function together in a commonare genes whose loss of function results in a proliferative
advantage for the cell carrying the mutation. Many tumor pathway. How does this pathway work? Together, the
four groups have made a number of intriguing observa-suppressors have been identified in humans, and inacti-
vation of tumor suppressors is likely to be obligatory for tions.
Hpo phosphorylates both Sav (Harvey et al., 2003;the development of cancer. Previous screens in Dro-
sophila for loss-of-function mutations that induce tissue Pantalacci et al., 2003; Wu et al., 2003) and Wts (Wu et
al., 2003) in vitro; moreover, the in vivo phosphorylationovergrowth—and thus constitute candidate tumor sup-
pressors—have identified a number of interesting loci. of both Sav (Pantalacci et al., 2003; Wu et al., 2003) and
Wts (Wu et al., 2003) requires Hpo, and is dependentTwo of these are warts (wts; Justice et al., 1995), also
known as lats (Xu et al., 1995) and salvador (sav; Tapon on the ability of Hpo to bind Sav (Harvey et al., 2003;
Pantalacci et al., 2003; Wu et al., 2003), which also bindset al., 2002), also known as shar-pei (shrp; Kango-Singh
et al., 2002). wts encodes a serine/threonine kinase and Wts (Tapon et al., 2002). Expression of a Hpo kinase-
dead mutant acts as a dominant negative, suggestingsav a multidomain protein with features of an adaptor.
Loss of wts or sav results in increased proliferation and that Hpo’s activity as a growth regulator requires it be
active as a kinase (Wu et al., 2003; Udan et al., 2003).increased resistance to cell death. Wts and Sav nega-
tively regulate proliferation and promote cell death, at However, Hpo kinase activity is not required for Sav
phosphorylation, suggesting that Hpo recruits other ki-least in part, by suppressing the transcription of Cyclin
E, a positive regulator of cell cycle progression (Kango- nases to Sav, perhaps to promote Sav stabilization (Pan-
talacci et al., 2003), and that Hpo’s most important sub-Singh et al., 2002; Tapon et al., 2002), and by promoting
the loss of DIAP1, a cell death inhibitor (Tapon et al., strate may be something else, for example, Wts. These
observations (with the caveats that complexes con-2002; Wu et al., 2003). Importantly, the human homolog
of sav is mutated in some cancer cell lines (Tapon et taining all three proteins have not been identified, and
that the significance of Wts phosphorylation by Hpoal., 2002), and loss of the mouse wts homolog, LATS1,
results in tumor development and hypersensitivity to is unclear) are consistent with a model in which Sav
functions to bring Hpo and Wts together, thus promotingcarcinogenic treatments (St. John et al., 1999), arguing
that both genes are conserved tumor suppressors. phosphorylation of Wts by Hpo (Wu et al., 2003). As
noted above, Hpo may also recruit other kinases to Sav,Work from four labs now adds a new player to this
story, the gene hippo (hpo; Udan et al., 2003; Harvey et leaving open the possibility of a more indirect mecha-
nism of action. This is an attractive model that mayal., 2003; Wu et al., 2003; Pantalacci et al., 2003). Loss
of hpo results in tissue overgrowth, and this is associ- capture part of the story. wts does show the strongest
overgrowth phenotype of the three mutants, consistentated with increased cell proliferation and decreased cell
death. hpo encodes a Drosophila member of the STE20 with the idea that Wts activity is a major output of this
pathway. However, double mutants between sav andfamily Ser/Thr kinases, and is most closely related to
human Mst2 and Mst1. The significance of this homol- wts show stronger overgrowth phenotypes than either
mutant alone (Tapon et al., 2002). Therefore, it seemsogy is suggested by the fact that expression of human
Mst2 can rescue the tissue overgrowth phenotype of likely that Sav and Wts, and perhaps Hpo as well, each
have growth regulatory functions that are independenthpo mutants (Wu et al., 2003).
How does Hpo regulate tissue growth? Jun N-terminal of the other proteins.
As with any exciting observations, these papers raisekinase (JNK) activation, which occurs in response to
expression of Mst (Graves et al., 1998) or Hpo (Panta- a number of questions. Hpo now has several targets,
DIAP1, Cyclin E, Hid, and Sav, which are likely to belacci et al., 2003), appears not to be critical for Hpo’s
activity as a growth regulator (Harvey et al., 2003; Panta- important in any conserved role of Mst proteins as tumor
suppressors. It will be interesting to determine how Hpolacci et al., 2003). Instead, at least part of the story again
involves negative regulation of Cyclin E and DIAP1. Hpo regulates these genes and whether Mst proteins have
similar activities. In addition, it is important to recognizesuppresses transcription of Cyclin E (Harvey et al., 2003;
Pantalacci et al., 2003; Udan et al., 2003; Wu et al., that critical targets of Hpo/Sav/Wts remain to be identi-
fied. Cells mutant for wts, sav, or hpo are accelerated2003) and DIAP1 (Udan et al., 2003; Wu et al., 2003).
Expression of Hpo also leads to phosphorylation of throughout every phase of the cell cycle, but yet the
cells are of normal size. Therefore, loss of these genesDIAP1. This is correlated with a decrease in DIAP1 stabil-
ity, suggesting that Hpo-dependent phosphorylation must stimulate cell growth (cell mass accumulation) in
addition to cell proliferation. Increased expression ofmay stimulate DIAP1 degradation (Harvey et al., 2003;
Pantalacci et al., 2003). Finally, Hpo overexpression pro- Cyclin E is sufficient to stimulate entry into S phase, but
it does not increase the rate of progression throughmotes transcriptional induction of the apoptosis inducer
and DIAP1 binding protein head involution defective other phases of the cell cycle (in fact there is a compen-
satory extension of S phase), nor does it promote cell(hid; Udan et al., 2003). Hid inhibits DIAP1 function
through several mechanisms. Therefore, it seems likely growth. Therefore, other targets must exist. Finally, Hpo,
Sav, and Wts are expressed ubiquitously. Presumably,that Hpo can use multiple mechanisms to promote cell
death. their activity is regulated—but by whom, and in what
contexts? Cells mutant for any of these three genesIn an effort to understand how Hpo exerts these ef-
fects, the various groups explored interactions with sav have a fascinating phenotype: they have not lost the
ability to differentiate, but they seem to be very poor atand wts, the two genes that give rise to similar loss-
of-function phenotypes. All three genes show genetic recognizing or responding to signals that would normally
promote differentiation and constrain growth within ainteractions with each other (Harvey et al., 2003; Tapon
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where they are processed or degraded (Katzmann etPtdIns(3,5)P2 Finds a Partner
al., 2002; Raiborg et al., 2003). Although not required
for the formation of MVB vesicles per se, PtdIns(3,5)P2
plays a key role in the sorting of some proteins into
Phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2) these vesicles. Yeast mutants defective in the Fab1 ki-
is required for the sorting of a subset of membrane nase, which converts phosphatidylinositol-3-phosphate
proteins at the late endosome. Unlike other phospho- (PtdIns(3)P) to PtdIns(3,5)P2, fail to deliver MVB vesicle
inositides, binding partners for PtdIns(3,5)P2 and its cargo proteins from the biosynthetic pathway into the
mechanism of action have not been characterized. vacuole lumen (Odorizzi et al., 1998).
New work by Friant et al. (2003) in this issue of Develop- Proteins that bind to PtdIns(3,5)P2 and regulate MVB
mental Cell describes the identification of a yeast ep- trafficking have been elusive, but now Friant et al. pro-
sin-like protein that binds PtdIns(3,5)P2 and functions vide an exciting breakthrough (Friant et al., 2003). These
in the transport of proteins through late endosomes authors identified a yeast epsin-like protein, Ent3, as a
to the lysosome-like vacuole. PtdIns(3,5)P2 binding protein that is required for trans-
port of cargo from the trans-Golgi network (TGN) to the
Phosphoinositides (PtdIns’s), phosphorylated deriva- vacuole. Ent3 and its close homolog, Ent5, are two of
tives of the membrane lipid phosphatidylinositol, are five yeast proteins that carry an ENTH (epsin N-terminal
crucial regulators of many basic cell biological pro-
homology) domain (De Camilli et al., 2002). Earlier this
cesses. The importance of PtdIns’s as signaling mole-
year, Ent3 and Ent5 emerged in a yeast two-hybrid
cules is particularly evident in the regulation of mem-
screen for proteins that bind to a clathrin adaptor com-
brane trafficking, where multiple kinases that synthesize
plex (AP1) and to the GGA monomeric clathrin adaptors.distinct PtdIns’s are required for efficient protein trans-
Gene deletion experiments revealed that Ent3 and Ent5port. Different versions of PtdIns’s have specific cellular
have redundant functions in clathrin localization to intra-locations, where they recruit proteins carrying modular
cellular membranes and for the transport of proteinsdomains that interact with the phosphorylated inositol
from the Golgi to endosomes (Duncan et al., 2003).head group.
Conventional epsins were originally identified as pro-PtdIns(3,5)P2 is thought to be concentrated at endo-
teins that bind to Eps15, a component of the plasmasomes and the lysosome, and is important for the sorting
membrane endocytic machinery. Epsins also bindof a subset of membrane proteins late in the endocytic
clathrin and are required at the internalization step ofpathway (Cooke, 2002; Katzmann et al., 2002). Mem-
endocytosis, where they bind phosphatidylinositol-4,5-brane proteins traveling through the biosynthetic and
bisphosphate (PtdIns(4,5)P2) through their ENTH do-endocytic pathways arrive at a late endosomal compart-
main. They act as accessory proteins that function atment known as the multivesicular endosome or body
the initial step of vesicle formation to recruit clathrin-(MVE/MVB). The MVB forms when portions of the late
based coats, and may link cargo proteins to the clathrin-endosome membrane invaginate and pinch off into the
based internalization machinery (Wendland, 2002). Fri-lumen to form intralumenal vesicles. Fusion of the MVB
ant and coworkers happened upon the epsin-like Ent3 inwith the lysosome results in delivery of MVB vesicle
lipids and proteins into the interior of the lysosome, a screen for new mutants that missort newly synthesized
